Akari Therapeutics
高管
查看带有其 9 名主要高管的组织结构图
Akari Therapeutics 搜索最多的简介
- Samir Patel, Interim Chief Executive Officer & Director
- Michael Grissinger, Director
- Ray Prudo, Executive Chairman of the Board
高管在Akari Therapeutics变化
- Samir Patel 曾任 Director, 现升职为 Interim Chief Executive Officer & Director (新闻发布的2024五月2号).
- Rachelle Jacques, President and Chief Executive Officer, 已经离开公司 (新闻发布的2024五月2号).
- Melissa Bradford-Klug, Chief Operating Officer, 已经离开公司 (新闻发布的2024五月2号).
创建提醒
跟踪 Akari Therapeutics 的高管变动
生物技术
Akari Therapeutics 拥有 2,332 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- March Biosciences 刚刚宣布为 28 筹款数百万美元。 (公布2024十二月3号).
- Lyell Immunopharma 已收购 ImmPACT Bio (公布2024十一月29号).
- Hopo Therapeutics 刚刚宣布为 226 筹款数百万美元。 (公布2024十一月29号).
生物技术 行业的其他推荐联系人
消息
Akari Therapeutics 的最新新闻稿
- Akari Therapeutics Narrows Pipeline Focus | Akari Therapeutics
- Akari Therapeutics Announces Positive Results from Recent Pre-Clinical Studies of Investigational PASylated® Nomacopan That Support the Potential to Advance Research Toward IND/IMPD for Clinical Trials in Geographic Atrophy | Akari Therapeutics
- Press Releases | Akari Therapeutics
- Akari Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Pipeline Progress | Akari Therapeutics
- Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA) | Akari Therapeuti
- Press Releases | Akari Therapeutics
- Akari Therapeutics Announces the Appointment of Accomplished Biotech Executive Melissa Bradford-Klug as Chief Operating Officer to Lead Business Development and Company Growth Strategies | Akari Therapeutics
- Akari Therapeutics Presents Results from the CASCADE and CORONET Studies in COVID-19 at the American Thoracic Society (ATS) 2022 Annual Meeting | Akari Therapeutics
- Akari Therapeutics Reports Full Year 2021 Financial Results and Highlights Clinical Progress | Akari Therapeutics
- Akari Therapeutics to Present Results from Compassionate Use of Nomacopan for COVID-19 (CORONET) and Identification of Clinical Deterioration Risk in COVID-19 (CASCADE) at the American Thoracic Society (ATS) 2022 Annual Meeting | Akari Therapeutics
- View more press releases Close
通过电子邮件
